Thyrocare Technologies Limited (BOM:539871)
485.70
-13.50 (-2.70%)
At close: Nov 9, 2026
Thyrocare Technologies Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Thyrocare Technologies stock has a consensus rating of "Strong Buy" and an average price target of ₹687.00. The average 1-year stock price forecast is 41.45% higher than the current stock price, while the lowest is ₹615.00 (+26.62%) and the highest is ₹780.00 (+60.59%).
Price Target: ₹687.00 (+41.45%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Thyrocare Technologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
10.11B
from 8.29B
Increased by 21.97%
Revenue Next Year
11.77B
from 10.11B
Increased by 16.35%
EPS This Year
13.65
from 10.54
Increased by 29.51%
EPS Next Year
15.90
from 13.65
Increased by 16.51%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.